Five Fake Treatments for Mesothelioma

Mesothelioma is a cancer caused by asbestos exposure. Sadly, most people who are diagnosed with mesothelioma die within five years of their mesothelioma diagnosis. In their quest for a cure, many patients turn to alternative "treatments." According to recent medical data, most of these "treatments" simply do not work, and many can cause serious harm. Read on to learn which fake mesothelioma treatments to avoid.

1. Rattlesnake Powder Therapy

Overcome on Mesothelioma!

There is a new hope for Mesothelioma patients. Health! They say is wealth. It has now been proved that Mesothelioma that affects the diaphragm and other internal Organs in the Chest cavity can now be treated by some Specialist doctors.

Treatments of mesothelioma

 Till now there is no certain and one hundred percent effective cure for this type of cancer. There were chemotherapy treatment developed for helping mesothelioma patients. This treatment was developed with electro shock based treatment. The idea is to give the patient some electric shocks, then those shocks were sent to brain to stop and help decreasing the pain in certain areas.

Is there time?

People diagnosed with cancer usually feel that the sooner they recover from their cancer, the better it will be. They may be of the opinion that they need to make decisions urgently. They may be worried that additional tests and consultations with other doctors will need more time that could be spent on cancer treatment.

Side Effects of Chemotherapy for Mesothelioma

Dry Mouth

Another common symptom is dryness of the mouth (xerostoma) that may be caused due to depression or anxiety, dehydration, or may be a result of side effects of medications such as antidepressants, tranquilizers, pain relievers and diuretics. Other potential causes include radiotherapy and chemotherapy treatments.

Pleural Malignant Mesothelioma:

Pleural malignant mesothelioma presents itself as a rare, highly aggressive neoplasm resulting mainly from the surface serosal cells found in the pleural cavity. A sharp rise in the incidence of mesothelioma has been recorded in the U.S. and Western Europe, and it has been predicted that around 250,000 deaths will occur as a result of malignant mesothelioma in the next 30 to 35 years. It can be difficult to diagnose diffuse pleural malignant mesothelioma. It is characterized by a poor survival rate, with fatalities generally occurring within 4-12 months after diagnosis has been made.